European drug watchdog backs Prozac for children

	Tweet

Europe’s medicine watchdog said on Tuesday that Prozac could be used to treat children aged eight years and over.

Despite controversy over giving antidepressants to adolescents, the European Medicines Agency said the benefits outweighed the risks in children with moderate to severe depression who failed to respond to psychological therapy.

Prozac, or fluoxetine, was originally developed by Eli Lilly and Co but is now widely available in generic versions since Lilly’s patent has expired.

RELATED STORIES:
Clozapine has serious health consequences   SSRIs and cardiovascular health   Antidepressants may affect fetus   SSRIs associated with severe violence in a small number of individuals   Use of Antidepressants Linked to Improvement in Fibromyalgia Symptoms   New findings on antidepressants during pregnancy are reason for caution, not alarm   Marijuana-like brain chemicals work as antidepressant   Antidepressants Help Men Decrease Alcohol Consumption, but Not Women   Study contradicts USA warning that an antidepressant can cause congenital abnormalities   Antidepressants may affect immune system   Anxiolytics in psychiatric practice   As Antidepressants Begin to Work, Hopelessness Can Linger   Third antidepressant seldom effective: study   Panorama programme lead to significant increase in adverse paroxetine reports   Miscellaneous Medications in psychiatric practice

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]